Effects of human papillomavirus type 16 E5 deletion mutants on epithelial morphology: functional characterization of each transmembrane domain

被引:35
作者
Barbaresi, Silvia [1 ]
Cortese, Marc S. [1 ]
Quinn, Jean [2 ]
Ashrafi, G. Hossein [1 ]
Graham, Sheila V. [3 ]
Campo, M. Saveria [1 ]
机构
[1] Univ Glasgow, Inst Comparat Med, Div Pathol Sci, Glasgow G61 1QH, Lanark, Scotland
[2] Univ Glasgow, Fac Med, Dermatol Sect, Glasgow G61 1QH, Lanark, Scotland
[3] Univ Glasgow, Fac Biochem & Life Sci, Div Infect & Immun, Glasgow G61 1QH, Lanark, Scotland
关键词
GROWTH-FACTOR RECEPTOR; KERATINOCYTE CELL-LINE; VACUOLAR H+-ATPASE; HLA CLASS-I; RAFT CULTURES; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; CERVICAL-CANCER; DOWN-REGULATION; PROTEIN;
D O I
10.1099/vir.0.016295-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Human papillomavirus type 16 (HPV-16) is the cause of cervical cancer. The HPV genome encodes three transforming proteins, E5, E6 and E7, E6 and E7 are the main transforming proteins of HPV, while the role of E5 is still poorly understood. Using three dimensional organotypic raft cultures we show that HaCaT human keratinocytes expressing HPV-16 E5 form a very perturbed epithelium, with simultaneous hyperkeratinization of some cells and defective differentiation of other cells. The basal layer is disturbed and many cells invade the collagen matrix. Many cells among the differentiated layers show characteristics of basal cells: progression through the cell cycle, expression of cytokeratin 14, lack of cytokeratin 1 and production of matrix metalloproteases (MMP). Using deletion mutants which encompass the three hydrophobic domains of E5, we have assigned the ability to promote invasion of the matrix to the first hydrophobic domain, and the capacity to induce MMP9 to the C-terminal four amino acids. We also show that invasion and production of MMP9 can be dissociated, as mutants that are still capable of invasion do not produce MMP9 and vice versa.
引用
收藏
页码:521 / 530
页数:10
相关论文
共 55 条
[1]   The relationship between connexins, gap junctions, tissue architecture and tumour invasion, as studied in a novel in vitro model of HPV-16-associated cervical cancer progression [J].
Aasen, T ;
Hodgins, MB ;
Edward, M ;
Graham, SV .
ONCOGENE, 2003, 22 (39) :7969-7980
[2]   A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems [J].
Adam, JL ;
Briggs, MW ;
McCance, DJ .
VIROLOGY, 2000, 272 (02) :315-325
[3]   Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice [J].
Akgül, B ;
Pfefferle, R ;
Marcuzzi, GP ;
Zigrino, P ;
Krieg, T ;
Pfister, H ;
Mauch, C .
EXPERIMENTAL DERMATOLOGY, 2006, 15 (01) :35-42
[4]  
Alazawi W, 2002, CANCER RES, V62, P6959
[5]  
ARAIBI LH, 2006, THESIS U GLASGOW
[6]   E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain [J].
Ashrafi, G. Hossein ;
Haghshenas, Mohammad ;
Marchetti, Barbara ;
Campo, M. Saveria .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (09) :2105-2112
[7]   E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I [J].
Ashrafi, GH ;
Haghshenas, MR ;
Marchetti, B ;
O'Brien, PM ;
Campo, MS .
INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (02) :276-283
[8]   Binding of bovine papillomavirus type 4 E8 to ductin (16K proteolipid), down-regulation of gap junction intercellular communication and full cell transformation are independent events [J].
Ashrafi, GH ;
Pitts, JD ;
Faccini, A ;
McLean, P ;
O'Brien, V ;
Finbow, ME ;
Campo, MS .
JOURNAL OF GENERAL VIROLOGY, 2000, 81 :689-694
[9]   Human papillomavirus type 16 E5 protein colocalizes with the antiapoptotic Bcl-2 protein [J].
Auvinen, E ;
Alonso, A ;
Auvinen, P .
ARCHIVES OF VIROLOGY, 2004, 149 (09) :1745-1759
[10]   Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway [J].
Behren, A ;
Simon, C ;
Schwab, RM ;
Loetzsch, E ;
Brodbeck, S ;
Huber, E ;
Stubenrauch, F ;
Zenner, HP ;
Iftner, T .
CANCER RESEARCH, 2005, 65 (24) :11613-11621